Medpace Holdings, Inc.

Symbol: MEDP

NASDAQ

392.57

USD

Market price today

  • 38.7448

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 12.16B

    MRK Cap

  • 0.00%

    DIV Yield

Medpace Holdings, Inc. (MEDP) Financial Statements

On the chart you can see the default numbers in dynamics for Medpace Holdings, Inc. (MEDP). Companys revenue shows the average of 846.938 M which is 0.175 % gowth. The average gross profit for the whole period is 265.274 M which is 0.121 %. The average gross profit ratio is 0.345 %. The net income growth for the company last year performance is 0.153 % which equals 0.628 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Medpace Holdings, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.225. In the realm of current assets, MEDP clocks in at 593.828 in the reporting currency. A significant portion of these assets, precisely 245.449, is held in cash and short-term investments. This segment shows a change of 7.684% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 0, if any, in the reporting currency. This indicates a difference of 0.000% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 142.122 in the reporting currency. This figure signifies a year_over_year change of -0.248%. Shareholder value, as depicted by the total shareholder equity, is valued at 558.95 in the reporting currency. The year over year change in this aspect is 0.447%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 298.4, with an inventory valuation of 0, and goodwill valued at 662.4, if any. The total intangible assets, if present, are valued at 35.81.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

balance-sheet.row.cash-and-short-term-investments

786.8245.428.3461.3
277.8
131.9
23.3
26.5
37.1
14.9
54.3

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

1145.4298.4253.4186.4
161
155.7
133.4
83.1
79.8
65.1
65.2

balance-sheet.row.inventory

0000
0
0
0
0
0.3
2.9
1.1

balance-sheet.row.other-current-assets

234.345052.343.2
34.9
29.4
21.4
20.4
16.1
11.9
12.7

balance-sheet.row.total-current-assets

2166.54593.8334690.9
473.7
317
178.1
130
133.2
94.7
133.3

balance-sheet.row.property-plant-equipment-net

1036.38265.4248.9222.7
198.8
99.4
52.3
48.7
43.8
37.5
38.1

balance-sheet.row.goodwill

2649.58662.4662.4662.4
662.4
662.4
661
661
661
661
670.3

balance-sheet.row.intangible-assets

144.5235.83841.4
46.5
54.4
69.2
98.7
136.1
186.7
249.9

balance-sheet.row.goodwill-and-intangible-assets

2794.11698.2700.4703.8
708.9
716.7
730.2
759.7
797.1
847.7
920.2

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

260.7774.448.125.1
0.5
0.4
0.7
6.3
0.1
0.2
0.1

balance-sheet.row.other-non-current-assets

88.472521.117.4
8.8
9.5
6.7
5.9
4.9
3.9
5.2

balance-sheet.row.total-non-current-assets

4179.7410631018.5969
917
826
789.8
820.7
845.9
889.3
963.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0

balance-sheet.row.total-assets

6346.281656.81352.51659.9
1390.7
1143.1
967.9
950.7
979.1
984
1096.9

balance-sheet.row.account-payables

118.931.933.125.7
26.6
22.4
16.7
16.7
10.9
8.7
6.3

balance-sheet.row.short-term-debt

885.0629350159.3
134.4
109.3
87.5
16.5
12.4
20.1
20.3

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

560.71142.1138.9131
115.1
45.2
79.7
205.1
151.3
377.9
491.5

Deferred Revenue Non Current

0000
0
0
84.5
11.5
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

6.99---
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

392.940.4257.727.6
23.5
19
4.9
85.8
79.6
54.1
48.9

balance-sheet.row.total-non-current-liabilities

671.08172.7162.6149.8
144.8
73.8
121.2
254.5
199.8
436.6
561.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

560.71142.1138.9131
115.1
45.2
0
0
0
0
0

balance-sheet.row.total-liab

4253.811097.9966.1707
584.9
416.8
378.2
447.2
368.4
570.6
694.9

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0

balance-sheet.row.common-stock

1.230.30.30.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3

balance-sheet.row.retained-earnings

-1012-221.6-359.8235
115.2
68.1
-41.5
-120.4
-9.6
-23
-14.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

-46.18-10.1-12.4-4.8
-0.1
-2.7
-2.5
-0.7
-3.7
-2.6
-1.6

balance-sheet.row.other-total-stockholders-equity

3149.41790.4758.3722.4
690.3
660.6
633.4
624.3
623.6
438.7
417.6

balance-sheet.row.total-stockholders-equity

2092.46559386.4952.9
805.8
726.3
589.7
503.5
610.7
413.5
402

balance-sheet.row.total-liabilities-and-stockholders-equity

6346.281656.81352.51659.9
1390.7
1143.1
967.9
950.7
979.1
984
1096.9

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0

balance-sheet.row.total-equity

2092.46559386.4952.9
805.8
726.3
589.7
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

6346.28---
-
-
-
-
-
-
-

Total Investments

0000
0
0
0
0
0
0
0

balance-sheet.row.total-debt

615.71142.1188.9131
115.1
45.2
79.7
221.6
163.6
377.9
491.5

balance-sheet.row.net-debt

-171.1-103.3160.6-330.3
-162.6
-86.7
56.4
195.1
126.5
363
437.2

Cash Flow Statement

The financial landscape of Medpace Holdings, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 0.130. The company recently extended its share capital by issuing 11.38, marking a difference of -0.324 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to -34629000.000 in the reporting currency. This is a shift of -0.106 from the previous year. In the same period, the company recorded 26.33, 2.02, and -155, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -11.38 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 116.38, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152013

cash-flows.row.net-income

312.51282.8245.4181.8
145.4
100.4
73.2
39.1
13.4
-8.7
24.8

cash-flows.row.depreciation-and-amortization

27.3626.322.321.1
19.5
23.2
38.8
46.5
58.1
69.5
30.5

cash-flows.row.deferred-income-tax

-24.92-25.1-23-37.1
0.5
10.1
3.9
3.2
-9
-12.7
6

cash-flows.row.stock-based-compensation

19.3920.521.414.5
13.8
20.7
6.5
4.5
9.8
22.3
2

cash-flows.row.change-in-working-capital

151.12106.5106.166.7
66.3
35.6
39.6
12.9
7.1
1.9
28.9

cash-flows.row.account-receivables

-24.82-48.3-66.9-25
-5.5
-21.3
-27
-2.9
-13.7
0
0

cash-flows.row.inventory

43.9466.2025
5.5
21.3
27.8
0.4
6.3
0
0

cash-flows.row.account-payables

-10.761.16.41.9
-2.6
4.7
1.3
4.8
0.7
2.5
0.6

cash-flows.row.other-working-capital

179.0587.5166.564.8
68.9
30.9
37.5
10.5
13.9
-0.6
28.3

cash-flows.row.other-non-cash-items

20.5222.415.916.3
13.2
11.9
-5.4
-8.8
12.3
11.8
5.9

cash-flows.row.net-cash-provided-by-operating-activities

505.98000
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-32.63-36.6-36.9-28.3
-31.3
-17.9
-16
-12.3
-13.5
-6.5
-4.6

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

10.042-1.9-3.1
0.1
-1.2
-0.9
0.1
0.1
0
0.1

cash-flows.row.net-cash-used-for-investing-activites

-22.6-34.6-38.7-31.4
-31.2
-19.1
-17
-12.2
-13.4
-6.4
-4.5

cash-flows.row.debt-repayment

-130-155-274.20
0
-80.4
-142.2
-42.4
-390.6
-116.1
-96.4

cash-flows.row.common-stock-issued

16.5711.422.117.6
16
6.5
0
0
173.6
0.6
1.2

cash-flows.row.common-stock-repurchased

-23.87-144-847.8-62.1
-98.3
0
0
-155.6
0
0
0

cash-flows.row.dividends-paid

0-11.4-22.10
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-23.43116.4346.3-44.5
-82.3
-73.9
0.6
100.1
159
-1
-0.6

cash-flows.row.net-cash-used-provided-by-financing-activities

-122.3-182.6-775.8-44.5
-82.3
-73.9
-141.6
-97.8
-58
-116.5
-95.9

cash-flows.row.effect-of-forex-changes-on-cash

-0.991.1-6.6-4
0.7
-0.2
-1.2
1.8
-0.6
-0.6
0.2

cash-flows.row.net-change-in-cash

360.09217.2-433183.5
145.8
108.6
-3.2
-10.9
19.7
-39.4
-2

cash-flows.row.cash-at-end-of-period

786.8245.428.3461.3
277.8
131.9
23.3
26.5
37.4
14.9
23.9

cash-flows.row.cash-at-beginning-of-period

426.7228.3461.3277.8
131.9
23.3
26.5
37.4
17.7
54.3
25.9

cash-flows.row.operating-cash-flow

505.98433.4388.1263.3
258.7
201.9
156.6
97.4
91.7
84.1
98.1

cash-flows.row.capital-expenditure

-32.63-36.6-36.9-28.3
-31.3
-17.9
-16
-12.3
-13.5
-6.5
-4.6

cash-flows.row.free-cash-flow

473.34396.7351.2235.1
227.3
184
140.6
85.1
78.2
77.7
93.6

Income Statement Row

Medpace Holdings, Inc.'s revenue saw a change of 0.292% compared with the previous period. The gross profit of MEDP is reported to be 524.5. The company's operating expenses are 187.68, showing a change of 22.075% from the last year. The expenses for depreciation and amortization are 26.33, which is a 0.178% change from the last accounting period. Operating expenses are reported to be 187.68, which shows a 22.075% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.209% year-over-year growth. The operating income is 336.82, which shows a 0.209% change when compared to the previous year. The change in the net income is 0.153%. The net income for the last year was 282.81.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152013

income-statement-row.row.total-revenue

1962.811885.814601142.4
925.9
861
704.6
436.2
421.6
359.1
272.9

income-statement-row.row.cost-of-revenue

1413.351361.31027.6814.2
647.2
615.3
489.1
261.5
249.5
202.7
148.4

income-statement-row.row.gross-profit

549.46524.5432.4328.2
278.7
245.7
215.5
174.7
172.1
156.4
124.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

41.01---
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

1.5---
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

12.981.322.321.1
19.5
23.2
1.1
-0.4
-0.4
0.2
2.4

income-statement-row.row.operating-expenses

194.77187.7153.7129.5
111.7
118.4
114.5
109.8
119.6
126.5
65.6

income-statement-row.row.cost-and-expenses

1608.1215491181.3943.8
758.9
733.7
603.5
371.3
369.1
329.2
214

income-statement-row.row.interest-income

3.3102.90.1
0.3
1.6
0
0
0
0
0

income-statement-row.row.interest-expense

7.43-0.52.9-0.1
0.3
1.6
8.2
7.6
19.4
27.3
18

income-statement-row.row.selling-and-marketing-expenses

1.5---
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

1.89-0.74.23.2
1.5
-2.4
1.1
-0.4
-11.1
-10.4
-1.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

12.981.322.321.1
19.5
23.2
1.1
-0.4
-0.4
0.2
2.4

income-statement-row.row.total-operating-expenses

1.89-0.74.23.2
1.5
-2.4
1.1
-0.4
-11.1
-10.4
-1.7

income-statement-row.row.interest-expense

7.43-0.52.9-0.1
0.3
1.6
8.2
7.6
19.4
27.3
18

income-statement-row.row.depreciation-and-amortization

26.0826.322.321.1
19.5
23.2
38.8
46.5
58.1
69.5
30.5

income-statement-row.row.ebitda-caps

381.37---
-
-
-
-
-
-
-

income-statement-row.row.operating-income

354.69336.8278.7198.6
167
127.3
101
64.9
52.5
20.6
58.9

income-statement-row.row.income-before-tax

362.43335.7282.9201.9
168.5
124.8
94
56.9
22
-7.8
39.1

income-statement-row.row.income-tax-expense

49.9352.937.520
23.1
24.4
20.8
17.8
8.5
0.8
14.3

income-statement-row.row.net-income

312.51282.8245.4181.8
145.4
100.4
73.2
39.1
13.4
-8.7
24.8

Frequently Asked Question

What is Medpace Holdings, Inc. (MEDP) total assets?

Medpace Holdings, Inc. (MEDP) total assets is 1656828000.000.

What is enterprise annual revenue?

The annual revenue is 1009445000.000.

What is firm profit margin?

Firm profit margin is 0.280.

What is company free cash flow?

The free cash flow is 15.347.

What is enterprise net profit margin?

The net profit margin is 0.159.

What is firm total revenue?

The total revenue is 0.181.

What is Medpace Holdings, Inc. (MEDP) net profit (net income)?

The net profit (net income) is 282810000.000.

What is firm total debt?

The total debt is 142122000.000.

What is operating expences number?

The operating expences are 187680000.000.

What is company cash figure?

Enretprise cash is 407010000.000.